BioHackers Choice
HomeDisclaimerSign in
← Back to compounds
Image coming soon

— peptide —

TB-500 10mg

Synthetic analog of thymosin beta-4 investigated for actin sequestration, angiogenesis, and tissue repair in preclinical research models.

From Retail $86 USDT

Member $75.00 USDT

Members save 15% — free to join

⏱Sold Out — Longer wait

Order now to reserve — we'll ship as soon as inventory is replenished.

Research-grade material. Documentation summarizes published literature in third-person scientific context. Not medical advice; not for human consumption.

— Pricing —

Three ways to source this compound.

All prices in USDT. Crypto pays settle directly to our wallet.

Single vial

Retail $86 USDT

Member $75.00 USDT

Members save 15% — free to join

1 vial · $75.00 USDT per vial

Most flexible

Pre-order reserves your spot in the restock queue.

USDT settlement · 3% off if you pay in crypto.

5-Pack

Save 14%

Retail $373 USDT

Member $324.00 USDT

Members save 15% — free to join

5 vials · $64.80 USDT per vial

Researcher's choice

Pre-order reserves your spot in the restock queue.

USDT settlement · 3% off if you pay in crypto.

10-Pack

Best value

Retail $542 USDT

Member $471.00 USDT

Members save 15% — free to join

10 vials · $47.10 USDT per vial

Pre-order reserves your spot in the restock queue.

USDT settlement · 3% off if you pay in crypto.

— The literature —

From the research record.

Thymosin beta-4 binds G-actin with high affinity through its central LKKTETQ motif and surrounding residues, sequestering monomeric actin and regulating the dynamic equilibrium between monomeric and filamentous actin. This sequestration activity influences cell motility, cytoskeletal remodeling, and migration responses required for wound repair.

Beyond actin binding, Tbeta4 has been shown to exert additional bioactivities including upregulation of vascular endothelial growth factor (VEGF), induction of laminin-5, and modulation of inflammatory cytokine networks. In endothelial cells, the protein promotes migration and tube formation in Matrigel assays. In cardiomyocyte and epicardial preparations, Tbeta4 has been observed to activate the epicardium and promote progenitor-like phenotypes through a pathway involving PINCH and integrin-linked kinase. The shorter TB-500 fragment retains actin-binding activity and is reported to engage some but not all of the downstream signaling effects of the full-length protein.

All compounds discussed are intended for research use only. Not for human consumption. Research-context information is educational and does not constitute medical advice.

View the full disclaimer →

— Available strengths —

5mg10mg